BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21726186)

  • 1. Adverse HBOC-endothelial dysfunction synergism: a possible contributor to adverse clinical outcomes?
    Biro GP
    Curr Drug Discov Technol; 2012 Sep; 9(3):194-203. PubMed ID: 21726186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.
    Yu B; Shahid M; Egorina EM; Sovershaev MA; Raher MJ; Lei C; Wu MX; Bloch KD; Zapol WM
    Anesthesiology; 2010 Mar; 112(3):586-94. PubMed ID: 20179495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin.
    Taverne YJ; de Wijs-Meijler D; Te Lintel Hekkert M; Moon-Massat PF; Dubé GP; Duncker DJ; Merkus D
    J Appl Physiol (1985); 2017 May; 122(5):1227-1237. PubMed ID: 28183818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.
    Jahr JS; Akha AS; Holtby RJ
    Curr Drug Discov Technol; 2012 Sep; 9(3):158-65. PubMed ID: 21745179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems biology of HBOC-induced vasoconstriction.
    Hai CM
    Curr Drug Discov Technol; 2012 Sep; 9(3):204-11. PubMed ID: 21726185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.
    Cabrales P; Friedman JM
    Antioxid Redox Signal; 2013 Jun; 18(17):2284-97. PubMed ID: 23249305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage.
    Fitzpatrick CM; Savage SA; Kerby JD; Clouse WD; Kashyap VS
    J Am Coll Surg; 2004 Nov; 199(5):693-701. PubMed ID: 15501108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
    Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
    J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin solutions and tissue oxygenation.
    Muir WW; Wellman ML
    J Vet Intern Med; 2003; 17(2):127-35. PubMed ID: 12683610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.
    Alayash AI
    Shock; 2019 Oct; 52(1S Suppl 1):41-49. PubMed ID: 29112106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin-based red blood cell substitutes and nitric oxide.
    Yu B; Bloch KD; Zapol WM
    Trends Cardiovasc Med; 2009 Apr; 19(3):103-7. PubMed ID: 19679268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction due to hemoglobin-based oxygen carrier infusion: A case report.
    Marrazzo F; Larson G; Sherpa Lama TT; Teggia Droghi M; Joyce M; Ichinose F; Watkins MT; Stowell C; Crowley J; Berra L
    J Crit Care; 2019 Jun; 51():213-216. PubMed ID: 30709560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide.
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S37-40. PubMed ID: 10976779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights from studies of blood substitutes in trauma.
    Moore EE; Johnson JL; Cheng AM; Masuno T; Banerjee A
    Shock; 2005 Sep; 24(3):197-205. PubMed ID: 16135956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes.
    Kavdia M; Tsoukias NM; Popel AS
    Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2245-53. PubMed ID: 12003834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential uses of hemoglobin-based oxygen carriers in critical care medicine.
    Creteur J; Vincent JL
    Crit Care Clin; 2009 Apr; 25(2):311-24, Table of Contents. PubMed ID: 19341911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect HBOC-201 and sodium nitrite resuscitation after uncontrolled haemorrhagic shock in swine.
    Moon-Massat P; Scultetus A; Arnaud F; Brown A; Haque A; Saha B; Kim B; Sagini E; McGwin G; Auker C; McCarron R; Freilich D
    Injury; 2012 May; 43(5):638-47. PubMed ID: 21094491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.
    Montezano AC; Touyz RM
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.